发明名称 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
摘要 Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
申请公布号 US9278100(B2) 申请公布日期 2016.03.08
申请号 US201113341695 申请日期 2011.12.30
申请人 Pharmacyclics LLC 发明人 Honigberg Lee;Verner Erik;Buggy Joseph;Loury David;Chen Wei
分类号 A61K31/519;A61P35/00;A61K31/00;A61K31/52;A61K31/337;A61K31/675;A61K31/704;A61K33/24;A61K39/395;A61K45/06 主分类号 A61K31/519
代理机构 Foley Hoag LLP 代理人 Foley Hoag LLP
主权项 1. A method for treating a solid tumor in an individual comprising administering to the individual in need thereof: (a) an anti-cancer agent; and (b) an irreversible covalent inhibitor of Bruton's tyrosine kinase (Btk) having the structure:or a pharmaceutically acceptable salt thereof,wherein the solid tumor is non-small cell lung cancer.
地址 Sunnyvale CA US